Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
A new study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy treatment in a manner that is similar to patients without that mutation, a discovery ...
Jul 23, 2021
0
4